They demonstrated that loss of YTHDF1 in classical DCs enhanced the cross-presentation of tumor antigens and the cross-priming of CD8+ T cells in vivo by binding to lysosomal protease transcripts and increasing their translation42. Here, CD8A is linked to neoplasm.